Open access
Oct 2026
A Repurposed Drug Combination Overcomes Paclitaxel Resistance and Minimizes Toxicity via Dual Metabolic and pH Modulation in Breast Cancer
Background: Paclitaxel (PTX) remains a cornerstone in breast cancer treatment, but its effectiveness is limited by both chemoresistance and significant side effects. A promising strategy to overcome these challenges is to repurpose existing drugs. The present investigation sought to explore the combined anticancer effi...
Istikrar M. Hade, A. H. Jumaa, K. Abdulla et al.
· Asian Pacific Journal of Can... · 0 citations